glp 1 drug How long should you take GLP-1 drugs? Study links longer use to lower heart risk GLP-1s: What They Are and

Weight loss has been long recognized as a disease-modifying therapy in IIH with patients being commonly recommended to lose 10% weight, although the amount of weight loss required to achieve disease remission remains unclear [1]

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Dore DD, Bloomgren GL, Wenten M, Hoffman C, Clifford CR, Quinn SG, Braun DK, Noel RA, Seeger JD

One analyst indicated at the beginning of 2024 that such medicines were on track to be the best-selling class of drugs in 2024, with close to US$50 billion in annual sales

Future studies will have to address how that finding can be reconciled with the abundance of clinical studies showing superior metabolic benefits of molecules activating the human GIP receptor, including dissection of weight loss components into fluid as well as bone-, fat-, and muscle mass

Small-molecule GLP-1RA litigation over the coming decade will likely generate more numerous, more independently contested patent challenges than peptide GLP-1RA litigation has

Adverse Effect Profile and Safety The most common adverse effects include gastrointestinal intolerance (nausea, vomiting, diarrhea), transient fatigue, and early satiety